<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue journalpublishing.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title-group><journal-title>Molecular Vision</journal-title></journal-title-group><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">288</article-id><article-id pub-id-type="publisher-id">2009MOLVIS0197</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Microarray analysis of retinal gene expression in <italic>Egr-1</italic> knockout mice</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Schippert</surname><given-names>Ruth</given-names></name></contrib><contrib contrib-type="author"><name><surname>Schaeffel</surname><given-names>Frank</given-names></name></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Feldkaemper</surname><given-names>Marita Pauline</given-names></name></contrib><aff id="aff1">Institute for Ophthalmic Research, Section of Neurobiology of the Eye, University Eye Hospital Tuebingen, Tuebingen, Germany</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: Marita Pauline Feldkaemper, Institute for Ophthalmic Research, Section of Neurobiology of the Eye, University Eye Hospital Tuebingen, Calwerstrasse 7/1, 72076 Tuebingen, Germany; Phone: +49 7071/29-87424; FAX: +49 7071/29-5196; email: <email xlink:href="marita.feldkaemper@uni-tuebingen.de">marita.feldkaemper@uni-tuebingen.de</email></corresp></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>10</day><month>12</month><year>2009</year></pub-date><volume>15</volume><fpage>2720</fpage><lpage>2739</lpage><history><date date-type="received"><day>09</day><month>6</month><year>2009</year></date><date date-type="accepted"><day>04</day><month>12</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Molecular Vision.</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>We found earlier that 42 day-old <italic>Egr-1</italic> knockout mice had longer eyes and a more myopic refractive error compared to their wild-types. To identify genes that could be responsible for the temporarily enhanced axial eye growth, a microarray analysis was performed in knockout and wild-type mice at the postnatal ages of 30 and 42 days.</p></sec><sec><title>Methods</title><p>The retinas of homozygous and wild-type <italic>Egr-1</italic> knockout mice (Taconic, Ry, Denmark) were prepared for RNA isolation (RNeasy Mini Kit, Qiagen) at the age of 30 or 42 days, respectively (n=12 each). Three retinas were pooled and labeled cRNA was made. The samples were hybridized to Affymetrix GeneChip Mouse Genome 430 2.0 Arrays. Hybridization signals were calculated using GC-RMA normalization. Genes were identified as differentially expressed if they showed a fold-change (FC) of at least 1.5 and a p-value &#x0003c;0.05. A false-discovery rate of 5% was applied. Ten genes with potential biologic relevance were examined further with semiquantitative real-time RT&#x02013;PCR.</p></sec><sec><title>Results</title><p>Comparing mRNA expression levels between wild-type and homozygous <italic>Egr-1</italic> knockout mice, we found 73 differentially expressed genes at the age of 30 days and 135 genes at the age of 42 days. Testing for differences in gene expression between the two ages (30 versus 42 days), 54 genes were differently expressed in wild-type mice and 215 genes in homozygous animals. Based on three networks proposed by Ingenuity pathway analysis software, nine differently expressed genes in the homozygous <italic>Egr-1</italic> knockout mice were chosen for further validation by real-time RT&#x02013;PCR, three genes in each network. In addition, the gene that was most prominently regulated in the knockout mice, compared to wild-type, at both 30 days and 42 days of age (protocadherin beta-9 [<italic>Pcdhb9</italic>]), was tested with real-time RT&#x02013;PCR. Changes in four of the ten genes could be confirmed by real-time RT&#x02013;PCR: nuclear prelamin A recognition factor (<italic>Narf</italic>), oxoglutarate dehydrogenase (<italic>Ogdh</italic>), selenium binding protein 1 (<italic>Selenbp1</italic>), and <italic>Pcdhb9</italic>. Except for <italic>Pcdhb9</italic>, the genes whose mRNA expression levels were validated were listed in one of the networks proposed by Ingenuity pathway analysis software. In addition to these genes, the software proposed several key-regulators which did not change in our study: retinoic acid, vascular endothelial growth factor A (<italic>VEGF-A</italic>), FBJ murine osteosarcoma viral oncogene homolog (<italic>cFos</italic>), and others.</p></sec><sec><title>Conclusions</title><p>Identification of genes that are differentially regulated during the development period between postnatal day 30 (when both homozygous and wild-type mice still have the same axial length) and day 42 (where the difference in eye length is apparent) could improve the understanding of mechanisms for the control of axial eye growth and may lead to potential targets for pharmacological intervention. With the aid of pathway-analysis software, a coarse picture of possible biochemical pathways could be generated. Although the mRNA expression levels of proteins proposed by the software, like <italic>VEGF</italic>, <italic>FOS</italic>, retinoic acid (RA) receptors, or cellular RA binding protein, did not show any changes in our experiment, these molecules have previously been implicated in the signaling cascades controlling axial eye growth. According to the pathway-analysis software, they represent links between several proteins whose mRNA expression was changed in our study.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta><custom-meta><meta-name>corr-author</meta-name><meta-value>Feldkaemper</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Myopia is becoming an increasing problem, especially in industrial nations. It is widely believed that both hereditary and environmental factors contribute to the development of myopia. Several molecules have already been identified in the retina that appear to be involved in the visual control of axial elongation of the eye (e.g., dopamine [<xref ref-type="bibr" rid="r1">1</xref>-<xref ref-type="bibr" rid="r3">3</xref>], retinoic acid [<xref ref-type="bibr" rid="r4">4</xref>-<xref ref-type="bibr" rid="r6">6</xref>], nitric oxide [<xref ref-type="bibr" rid="r7">7</xref>-<xref ref-type="bibr" rid="r9">9</xref>], vasoactive intestinal polypeptide [<xref ref-type="bibr" rid="r10">10</xref>-<xref ref-type="bibr" rid="r12">12</xref>]). Another factor that was found to be involved was the transcription factor Egr-1 (early growth response protein-1), the mammalian ortholog to the avian protein ZENK (also called Tis8, Ngfi-A, Kro&#x000d7;&#x02212;24, Zif268 in other species). By means of immunocytochemistry it was initially found that the number of ZENK-immunoreactive amacrine cells in the retina of chicks is increased under conditions that lead to a reduction in eye growth (myopic defocus, recovery of myopia) and decreased under conditions that enhance ocular growth (hyperopic defocus, form-deprivation). These changes were most prominent and distinct in a specific subset of amacrine cells, the glucagon-containing amacrine cells [<xref ref-type="bibr" rid="r13">13</xref>,<xref ref-type="bibr" rid="r14">14</xref>]. Recently, this bi-directional response was detected by means of immunohistochemistry in another glucagon-containing cell type of the chicken retina as well, the so-called bullwhip-cells [<xref ref-type="bibr" rid="r15">15</xref>]. Moreover, a downregulation of <italic>Egr-1</italic> mRNA in total retinal tissue was found in mice after short periods of form-deprivation [<xref ref-type="bibr" rid="r16">16</xref>]. All of these experiments suggested that Egr-1 (ZENK) is an important factor in controlling eye growth, at least in some animal models for myopia. However, it should be noticed that mRNA levels of <italic>Egr-1</italic> in the total retina of chicks do not seem to show this bidirectional response consistently. Although <italic>ZENK</italic> mRNA levels are upregulated in total retinal samples within one hour after diffuser removal of former form-deprived chicks (recovery of myopia) [<xref ref-type="bibr" rid="r17">17</xref>], treatment with both minus lenses and plus lenses for one day reduced the amount of <italic>ZENK</italic> mRNA in the total retina of chicks in both cases, suggesting that the role of <italic>Egr-1</italic> is complex and may vary among special cell types [<xref ref-type="bibr" rid="r18">18</xref>,<xref ref-type="bibr" rid="r19">19</xref>]. Unfortunately, no study is available that investigated the time course of <italic>Egr-1</italic> mRNA changes in detail. Therefore, current knowledge about the regulation of <italic>Egr-1</italic> during increased or decreased eye growth is still limited.</p><p>Studies on <italic>Egr-1</italic> knockout mice were in line with the hypothesis that <italic>Egr-1</italic> has a function in the regulation of eye growth. Homozygous knockout mice, lacking functional Egr-1 protein, developed relative axial myopia at the age of 42 and 56 days (compared to heterozygous and wild-type <italic>Egr-1</italic> knockout mice [<xref ref-type="bibr" rid="r20">20</xref>]). The difference in axial length declined with increasing age, but the differences in the refractive state persisted. Paraxial schematic eye modeling suggested that other optical elements, possibly the lens, had also changed in the <italic>Egr-1</italic> knockout mice. This is not surprising, given that Egr-1 was absent not only from retinal amacrine cells but from all cells of the body. The effect of lacking Egr-1 protein should have long-ranging effects on other cells in the retina, eye, and the autonomic nervous system or the endocrine system.</p><p>Egr-1 is known to have a function in a variety of biologic processes (e.g., cell proliferation [<xref ref-type="bibr" rid="r21">21</xref>], brain plasticity and learning [<xref ref-type="bibr" rid="r22">22</xref>], apoptosis [<xref ref-type="bibr" rid="r23">23</xref>]) and several target genes of Egr-1 have already been identified. <italic>Egr-1</italic>-overexpression in synovial fibroblasts leads to an increased expression of collagen type 1 and of tissue inhibitor of metalloproteinases type 1 and 3 (TIMP1 and TIMP3) [<xref ref-type="bibr" rid="r24">24</xref>]. Since the induction of myopia is associated with scleral thinning through reduced accumulation of collagen and increased degradation of scleral tissue [<xref ref-type="bibr" rid="r25">25</xref>-<xref ref-type="bibr" rid="r27">27</xref>], the reduction of Egr-1-stimulated collagen expression and the reduced inhibition of degrading enzymes (such as the matrix-metalloproteinases that are repressed by TIMPs) that could take place in animals without functional Egr-1 protein, could explain the myopic phenotype of these mice. Other genes that are already known to be influenced by Egr-1 are for instance platelet-derived growth factor-A and -B (<italic>PDGF-A</italic> and <italic>-B</italic>) [<xref ref-type="bibr" rid="r28">28</xref>,<xref ref-type="bibr" rid="r29">29</xref>], basic fibroblast growth factor (<italic>bFGF</italic>) [<xref ref-type="bibr" rid="r30">30</xref>] and transforming growth factor-beta (<italic>TGF-&#x003b2;</italic>) [<xref ref-type="bibr" rid="r31">31</xref>].</p><p>Because of the complex role of <italic>Egr-1</italic> in the regulation of various other proteins, and the differences in axial eye length between the Egr-1 knockout mice and the wild-type mice, we have studied the role of Egr-1 in the retina in more detail. Retinal samples of <italic>Egr-1</italic> knockout and wild-type mice at the age of 30 days (no difference in axial eye length yet) and 42 days (already a difference in axial eye length of 59&#x000a0;&#x000b5;m) were compared regarding their mRNA expression changes, both between the two genotypes and within the same genotype between the two age groups.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Animals</title><p>Experiments were conducted in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and were approved by the University Commission for Animal Welfare. Egr-1 knockout mice, generated on C57/BL6 background, were purchased from Taconic (Ry, Denmark) and bred in the animal facilities of the institute after a breeding permission was obtained from the company. Since female homozygous knockout mice are sterile because of a deficiency of luteinizing hormone-beta (which is due to the lack of Egr-1 [<xref ref-type="bibr" rid="r32">32</xref>]), only heterozygous females were bred. Animals were housed in standard cages with their littermates under a 12 h light/dark cycle with unrestricted access to water and food pellets. Illumination was provided by standard fluorescent lamps and was approximately 200&#x000a0;lx. Standard PCR was performed to determine genotype (specific primer sequences provided by Taconic) and gender (with primers designed for the gene encoding the sex-determining region Y represents as SRY).</p><p>Male mice were killed by an overdose of diethyl ether at the mean age of 30 days (p29-p31) or 42 days (p41-p43). Eyes were enucleated and retinas were prepared carefully to ensure that the samples were not contaminated with retinal pigment epithelium. Tissue was snap-frozen in liquid nitrogen. The retinas of 12 homozygous Egr-1 knockout mice (hm) and 12 wild-type mice (wt) of the same strain were prepared for both time points (48 animals in total). Three single retinas from different mice were then pooled to obtain four samples per group (wt/30, wt/42, hm/30, hm/42), and RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions.</p></sec><sec><title>Microarray</title><p>Quality check of RNA, cDNA synthesis and labeling and the actual microarray analysis was performed by the Affymetrix Resource Facility at the University of Tuebingen. The quality of total RNA was monitored by Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA) following the manufacturer's instructions. Generation of double-stranded cDNA, preparation and labeling of cRNA, hybridization to 430 2.0 Mouse Genome Arrays (Affymetrix, Santa Clara, CA), washing, and scanning were performed according to the standard Affymetrix protocol. Scanning and analysis were performed using the Affymetrix Microarray Suite Software (version 5.0) and the signal intensities were analyzed using ArrayAssist 5.5.1 (Stratagene, La Jolla, CA).</p><p>Data were normalized using the GC-RMA normalization method which uses the GC content of the probes in normalization with RMA (Robust Multi-Array). To correct for multiple testing, a false-discovery rate of 5% was applied. All comparisons of mRNA expression levels between the groups were performed using un-paired <italic>t</italic>-tests. Genes were identified as differentially expressed if they showed a fold-change (FC) of at least 1.5 with a p value lower than 0.05. Fold change was calculated by dividing the experimental value (lens-treated, t) by the control value (untreated control, c). If the relative signal intensity of the control was higher than the intensity of the treated samples, the negative reciprocal was calculated (-c/t). A fold change of 1 or &#x02212;1 therefore indicates no change, while a fold change of 2 equals a doubling in product, and a fold change of &#x02212;2 equals a halving in transcript abundance.</p><p>The data discussed in this publication have been deposited in the National Center for Biotechnology Information (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/">NCBI's</ext-link>) Gene Expression Omnibus (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">GEO</ext-link>) and are accessible through GEO Series accession number <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE16974">GSE16974</ext-link>.</p></sec><sec><title>Pathway analysis</title><p>The list of differently expressed genes was subjected to a subsequent post-analysis task to find the main biologic processes associated with the experimental system. The &#x0201c;Ingenuity Pathways Analysis&#x0201d; Software 5.0 (IPA, <ext-link ext-link-type="uri" xlink:href="http://www.ingenuity.com">Ingenuity Systems</ext-link>) was applied to elucidate putative pathways associated with the gene expression changes in the retinas of the <italic>Egr-1</italic> knockout mice between the age of 30 days and 42 days. For this purpose, 215 genes which were classed as &#x0201c;differently expressed,&#x0201d; e.g., those whose retinal mRNA expression in the knockout mice at p30 was significantly different from the expression at p42, were analyzed and theoretical networks and pathways were computed. The IPA is a manually curated database of functional interactions and contains previously published findings from peer-reviewed publications. Interactions between proteins and molecules in the proposed networks are therefore supported by published information which is associated by the program with known biologic pathways. It should be noted here that the interactions presented in the networks are not specific for the retina or brain tissue, as the database contains literature from many different research areas. If the mRNA expression levels of many proteins present in one proposed network have actually been found to be changed, it is likely that they are connected with each other and that their changes may represent a response to the lack of Egr-1.</p></sec><sec><title>Real-time RT&#x02013;PCR</title><p>Based on three networks found in the homozygous <italic>Egr-1</italic> knockout mice computed by Ingenuity Pathways Analysis Software (hm/30 versus hm/42, see <xref ref-type="fig" rid="f1">Figure 1A-C</xref>), nine genes were chosen for further validation of their expression changes by real-time RT&#x02013;PCR (three genes per network). For network A we chose: A kinase anchor protein 9 (<italic>Akap9</italic>), SET domain, bifurcated 1 (<italic>Setdb1</italic>) and staphylococcal nuclease domain containing 1 (<italic>Snd1</italic>). The three genes representing network B were: corticotropin releasing hormone (<italic>Crh</italic>), insulin-like growth factor binding protein 3 (<italic>Igfbp3</italic>), and LIM and SH3 protein 1 (<italic>Lasp1</italic>). Finally, from network C we chose: nuclear prelamin A recognition factor (<italic>Narf</italic>), oxoglutarate dehydrogenase (<italic>Ogdh</italic>), and selenium binding protein 1 (<italic>Selenbp1</italic>). In addition, protocadherin-beta 9 (<italic>Pcdhb9</italic>), the gene that showed the highest fold-change in mRNA expression levels in a comparison between wild-type and knockout mice, was tested with real-time PCR.</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>Networks predicted by Ingenuity Pathway Analysis in the homozygous Egr-1 knockout mice. Networks proposed by Ingenuity Pathways Analysis Software. All genes whose mRNA expression levels were found to be differentially regulated in the knockout mice between the age of 30 days and 42 days are highlighted in gray. Encircled are those genes that were chosen for validation by real-time RT&#x02013;PCR. A detailed legend describing the symbols used in this scheme is enclosed in the figure. Asterisks denote changes in gene expression that were validated using real-time PCR.</p></caption><graphic xlink:href="mv-v15-2720-f1"/></fig><p>The primer sequences, product lengths, NCBI accession numbers and network classifications of the genes tested are shown in <xref ref-type="table" rid="t1">Table 1</xref>. From each sample, 1&#x000a0;&#x000b5;g of RNA was reverse transcribed using M-MLV reverse transcriptase (Promega, Mannheim, Germany), 500 ng oligo (dT)15 primer and 50 ng of a random primer mixture (Invitrogen, Solingen, Germany). Semiquantitative real-time RT&#x02013;PCR was performed with the aid of QuantiTect SYBR Green master mix kit of Qiagen on the iCycler iQ Multicolor Real-Time PCR Detection System from Bio-Rad (Hercules, CA). All samples were analyzed in triplicate with a template amount corresponding to 2 ng of RNA. Hypoxanthine-phosphoribosyl-transferase (<italic>HPRT</italic>) was used as a housekeeping gene and all PCR products were subjected to automated sequencing to ensure amplification of the correct sequences.</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Description of primers.</title></caption><table frame="hsides" rules="groups"><col width="56" span="1"/><col width="84" span="1"/><col width="196" span="1"/><col width="196" span="1"/><col width="65" span="1"/><col width="56" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Gene</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>NCBI accession number</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Forward primer (5&#x02032;-3&#x02032;)</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Reverse primer (5&#x02032;-3&#x02032;)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Amplicon</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Network</bold></th></tr></thead><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>Akap9</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/125661047">NM_194462.2</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GTCTTCAGATGGTAGAAAAGGA<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GTTAGCTGTGAGCTGAGTTATG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">173 bp<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>Setdb1</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/51092286">NM_018877.2</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GATAGCTCCTGCCGAGACTTC<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTGCCATCCACCTCTTCAAC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">143 bp<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>Snd1</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/77404391">NM_019776.2</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ACGCTGATGAGTTTGGCTACA<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCACGACAGAGGAGGTTTC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">171 bp<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>Crh</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/45429989">NM_205769.1</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CATTCTTGAGGGGTGGCTA<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTCTTACACAACCAAATTGACC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">116 bp<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">B<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>Igfbp3</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/111378399">NM_008343.2</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TCTTGGGGTCCTTCTCAAA<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCTCCAGACACAGGCTCC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">194 bp<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">B<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>Lasp1</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/142349718">NM_010688.3</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ATACCATGAGGAGTTTGAGAAG<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ACCATAGGACGAGGTCATCT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">196 bp<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">B<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>Narf</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/31541950">NM_026272.2</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GATAGCATCCCTTCAGCCCT<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TTCATCAAACCCCTTTATCTCC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">156 bp<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>Ogdh</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/114796649">NM_010956.3</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GCTAGTCTCTTCCTTGACTG<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">AACTTACTCATGCCATTGTC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">184 bp<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>Selenbp1</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/118130509">NM_009150.3</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GTGCAACGTGAGCAGTTT<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTGCATCCCCAGGCTTCT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">161 bp<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>Pcdhb9</italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/113866010">NM_053134.3</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TTTAGGAGAAACTACCTTGTGC<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TGAGCATTAAAGTCACTTGAGG<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">195 bp<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">none<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1"><italic>HRPT</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/96975137">NM_013556.2</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">CCAGTAAAATTAGCAGGTGTTC</td><td valign="top" align="left" rowspan="1" colspan="1">GATAAGCGACAATCTACCAGAG</td><td valign="top" align="center" rowspan="1" colspan="1">179 bp</td><td valign="top" align="center" rowspan="1" colspan="1">none</td></tr></tbody></table><table-wrap-foot><p>Shown are the NCBI accession numbers, primer sequences, product sizes and the assignment to the networks of the genes that were further tested with real-time RT&#x02013;PCR.</p></table-wrap-foot></table-wrap></sec><sec><title>Statistics and data analysis</title><p>Data were analyzed using the software JMP 5.1 (SAS Institute, Cary, NC) and Excel (Microsoft Corporation, Redmond, WA). The mean cycle threshold (Ct) value of each triplet was taken and the mean normalized expression (MNE) was computed as previously described [<xref ref-type="bibr" rid="r33">33</xref>]. To test for differences between the four groups (wt/30, wt/42, hm/30, hm/42), ANOVA&#x02019;s (ANOVA) were applied for each gene. In case the ANOVA was significant (p&#x0003c;0.05), a paired Student's <italic>t</italic>-test was applied as a post-hoc test to test for differences between wt/30 versus wt/42 and hm/30 versus hm/42.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Microarray</title><sec><title>Age-related comparisons (wt/30 versus wt/42) in wild-type mice</title><p>Comparing mRNA expression levels between the 30 days old and the 42 days old wild-type mice, 54 genes were classified as differentially expressed (with a minimum FC of &#x000b1;1.5 and a p-value lower than 0.05). The corresponding genes are listed in <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/v15/a288/app-1.pdf">Appendix 1</ext-link> together with the fold-changes and p-values that were determined in homozygous Egr-1 knockout mice at the two ages. Seventeen genes showed reduced mRNA expression in the 42 days old wild-type mice compared to the 30 days old mice. Thirty-seven genes were higher expressed. The maximum fold-changes were &#x02212;2.40 and 2.62, respectively.</p></sec></sec><sec><title>Age-related comparisons (hm/30 versus hm/42) in <italic>Egr-1</italic> knockout mice</title><p>Two hundred fifteen genes had changed their expression levels in the homozygous <italic>Egr-1</italic> knockout mice between the age of 30 and 42 days (see <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/v15/a288/app-2.xls">Appendix 2</ext-link> for a list of those genes). Higher mRNA expression was found in 176 genes at 42 days, compared to 30 days, while 39 genes showed reduced mRNA expression. Age-dependent changes in gene expression ranged here between 2.49 fold and &#x02212;4.01 fold. A pathway analysis was performed based on this list of differentially expressed genes. Genes that were further studied using semiquantitative real-time RT&#x02013;PCR are shown in bold in <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/v15/a288/app-2.xls">Appendix 2</ext-link>.</p><p>Eight genes were differently expressed at the two ages in both wild-type and homozygous <italic>Egr-1</italic> knockout mice (shown in italics and underlined in <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/v15/a288/app-1.pdf">Appendix 1</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/v15/a288/app-2.xls">Appendix 2</ext-link>). The directions of their changes were the same in wild-type- and homozygous Egr-1 knockout mice.</p></sec><sec><title><italic>Egr-1</italic>-related comparisons (wt/30 versus hm/30 and wt/42 versus hm/42)</title><p>In the 30 days old mice, the lack of Egr-1 was associated with different mRNA expression levels of 73 genes, with 39 upregulated and 34 downregulated (wt/30 versus hm/30, see <xref ref-type="table" rid="t2">Table 2</xref> for a list of those genes). In the 42 days old mice, 135 genes were differently expressed compared to the wild-type. One hundred and thirteen genes were upregulated, and 22 genes were downregulated (wt/42 versus hm/42, see <xref ref-type="table" rid="t3">Table 3</xref> for a list of those genes).</p><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>List of genes that were differentially expressed between wild-type and homozygous <italic>Egr-1</italic> knockout mice at the age of 30 days (<underline>wt/30 versus hm/30</underline>).</title></caption><table frame="hsides" rules="groups"><col width="84" span="1"/><col width="93" span="1"/><col width="252" span="1"/><col width="65" span="1"/><col width="65" span="1"/><col width="65" span="1"/><col width="65" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Affymetrix ID</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Gene symbol</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Gene title</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>FC (wt/p30 vs hm/p30)</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>p-value (wt/p30 vs hm/p30)</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>FC (wt/p42 vs hm/p42)</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>p-value (wt/p42 vs hm/p42)</bold></th></tr></thead><tbody><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Translation factor activity (1)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1438686_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Eif4g1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">eukaryotic translation initiation factor 4, gamma 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.71<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0207<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.15<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.1370<hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Electron Carrier Activity (1)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1417590_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Cyp27a1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">cytochrome P450, family 27, subfamily a, polypeptide 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.54<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0047<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.09<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5424<hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Structural molecule activity (2)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1418306_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Crybb1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">crystallin, beta B1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.98<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0291<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.40<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5518<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1419011_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Cryba2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">crystallin, beta A2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;2.02<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0236<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.92<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.3953<hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Enzyme Regulator Activity (3)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1422477_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Cables1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Cdk5 and Abl enzyme substrate 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.57<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0067<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.03<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8213<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1423062_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Igfbp3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">insulin-like growth factor binding protein 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2.05<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0281<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.09<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6077<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1421138_a_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Pkib<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">protein kinase inhibitor beta<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.63<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0356<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.16<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.2212<hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Transcription Regulator Activity (3)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1445710_x_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Duxbl<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">double homeobox B-like<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.82<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0010<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.19<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.4352<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1417065_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Egr1</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>early growth response 1</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>1.99</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0000</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>1.79</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0004</underline></italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1417930_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Nab2</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Ngfi-A binding protein 2</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;2.40</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0035</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;2.88</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0001</underline></italic><hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Molecular Transducer Activity (4)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1428538_s_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Rarres2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">retinoic acid receptor responder (tazarotene induced) 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.52<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0401<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.02<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9101<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1430295_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Gna13<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">guanine nucleotide binding protein, alpha 13<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.68<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0012<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.08<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.4900<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1434447_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Met<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">met proto-oncogene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.69<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0380<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.17<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.1753<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1418552_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Opn1sw<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">opsin 1 (cone pigments), short-wave-sensitive<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.72<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0000<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.40<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0233<hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Transporter Activity (5)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1424338_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Slc6a13<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">solute carrier family 6, member 13<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.66<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0068<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.37<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.1628<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1443823_s_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Atp1a2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ATPase, Na<sup>+</sup>/K+ transporting, alpha 2 polypeptide<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.76<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0136<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.09<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6566<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1438945_x_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Gja1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">gap junction membrane channel protein alpha 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.83<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0229<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.14<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5575<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1436044_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Scn7a</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>sodium channel, voltage-gated, type VII, alpha</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;1.59</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0005</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;1.74</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0000</underline></italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1415844_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Syt4</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>synaptotagmin IV</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;2.55</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0000</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;2.26</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0000</underline></italic><hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Catalytic Activity (20)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1452839_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Dph5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">DPH5 homolog (S. cerevisiae)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.51<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0197<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.25<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0094<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1440926_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Flt1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">FMS-like tyrosine kinase 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.56<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0263<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.18<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.2562<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1428987_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Dynlrb2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">dynein light chain roadblock-type 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.62<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0199<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.49<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.2117<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1449623_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Txnrd3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">thioredoxin reductase 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.64<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0080<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.07<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6259<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1417024_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Hars</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>histidyl-tRNA synthetase</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>1.66</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0000</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>1.66</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0000</underline></italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1440179_x_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ibrdc1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">IBR domain containing 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.70<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0067<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.1262<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1455385_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Exoc6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">exocyst complex component 6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.76<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0093<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.09<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6328<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1454713_s_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Hdc<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">histidine decarboxylase<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.80<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0150<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.21<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0278<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1449106_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Gpx3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">glutathione peroxidase 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.93<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0472<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.80<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.2441<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1452975_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Agxt2l1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">alanine-glyoxylate aminotransferase 2-like 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2.29<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0072<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.24<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.1606<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1424325_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Esco1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">establishment of cohesion 1 homolog 1 (S. cerevisiae)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.53<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0239<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.22<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.1796<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1430996_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Etnk1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ethanolamine kinase 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.53<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0076<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.13<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.4668<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1441486_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Fkbp15<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">FK506 binding protein 15<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.54<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0040<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.38<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.1085<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1434734_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">E130016E03Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA E130016E03 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.57<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0446<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9955<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1458363_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Zdhhc17<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">zinc finger, DHHC domain containing 17<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.58<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0012<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.25<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0814<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1440553_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Mecr<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">mitochondrial trans-2-enoyl-CoA reductase<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.58<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0262<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.16<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.1769<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1445632_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ogdh<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">oxoglutarate dehydrogenase (lipoamide)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.58<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0050<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.09<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6322<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1440351_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Birc4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Baculoviral IAP repeat-containing 4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.75<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0283<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.02<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8804<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1457732_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Pcmtd2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Protein-L-isoaspartate O-methyltransferase domain containing 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;2.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0016<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.01<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9495<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1439843_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Camk4</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>calcium/calmodulin-dependent protein kinase IV</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;2.19</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0000</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;1.95</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0006</underline></italic><hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Binding (24)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1438295_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Glcci1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Glucocorticoid induced transcript 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.50<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0044<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.21<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.2239<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1441317_x_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Jakmip1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">janus kinase and microtubule interacting protein 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.50<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0256<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.04<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5407<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1434203_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Fam107a<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Fam107a family with sequence similarity 107, member A<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.52<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0244<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.07<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.4713<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1451602_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Snx6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">sorting nexin 6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.55<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0456<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.06<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6713<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1428942_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Mt2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">metallothionein 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.57<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0008<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.30<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0078<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1435386_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Vwf<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Von Willebrand factor homolog<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.60<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0158<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.31<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0166<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1452217_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ahnak<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">AHNAK nucleoprotein (desmoyokin)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.61<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0073<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.01<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9348<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1422660_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">LOC671237<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">similar to Putative RNA-binding protein 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.62<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0121<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.04<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6603<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1456351_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Brd8</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>bromodomain containing 8</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>1.67</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0003</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>1.66</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0005</underline></italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1429239_a_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Stard4</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>StAR-related lipid transfer (START) domain containing 4</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>2.18</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0020</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>1.79</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0295</underline></italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1417580_s_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Selenbp1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">selenium binding protein 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2.34<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0102<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.23<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0676<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1451692_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Tmco6</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>transmembrane and coiled-coil domains 6</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>4.10</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0000</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>2.73</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0002</underline></italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1422877_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Pcdhb12<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">protocadherin beta 12<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.52<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0070<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.41<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0010<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1437694_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">BB114266<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Expressed sequence BB114266<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.53<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0318<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.13<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.1606<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1421132_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Pvrl3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">poliovirus receptor-related 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.56<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0153<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.02<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.7130<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1436981_a_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ywhaz<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">tyrosine 3-monooxygenase activation protein, zeta<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.56<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0024<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.04<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5712<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1440632_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Pcdhb4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">protocadherin beta 4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.57<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0446<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.58<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0833<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1449527_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Pcdhb7</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>protocadherin beta 7</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;1.58</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0155</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;1.64</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0016</underline></italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1430569_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ttc9c<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">tetratricopeptide repeat domain 9C<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.58<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0089<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.02<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8478<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1443950_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">A630042L21Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA A630042L21 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.64<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0345<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.33<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0600<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1421953_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Crkl<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">v-crk sarcoma virus CT10 oncogene homolog (avian)-like<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.66<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0216<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.01<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9614<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1426458_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Slmap<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">sarcolemma associated protein<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.68<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0164<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.39<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.1939<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1443315_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Dmd</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Dystrophin</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;2.45</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0492</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>1.66</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0103</underline></italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>1422640_at</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>Pcdhb9</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>protocadherin beta 9</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>&#x02212;14.34</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>0.0000</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>&#x02212;17.48</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>0.0000</bold><hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Unknown (8)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1417460_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ifitm2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">interferon induced transmembrane protein 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.53<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0478<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.03<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.7015<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1417275_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Mal<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">myelin and lymphocyte protein, T-cell differentiation protein<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.59<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0059<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.16<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.1316<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1453632_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">4930538K18Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 4930538K18 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.61<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0215<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.07<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5032<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1434817_s_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Rprd2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Regulation of nuclear pre-mRNA domain containing 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.75<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0387<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.13<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.2222<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1460049_s_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1500015O10Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 1500015O10 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.77<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0163<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.34<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.3090<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1447553_x_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ric3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Resistance to inhibitors of cholinesterase 3 homolog (C. elegans)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.56<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0314<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.33<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.1653<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1451634_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2810051F02Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 2810051F02 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.63<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0438<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.107<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5203<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1428909_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>A130040M12Rik</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>RIKEN cDNA A130040M12 gene</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;1.90</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0001</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;1.62</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0368</underline></italic><hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Not Annotated (2)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1441430_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.56<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0106<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.13<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.2617<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1442733_at</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.55</td><td valign="top" align="left" rowspan="1" colspan="1">0.0244</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.05</td><td valign="top" align="left" rowspan="1" colspan="1">0.7378</td></tr></tbody></table><table-wrap-foot><p>Shown are Affymetrix ID, gene symbol, gene title, fold change (FC) and p-values that indicate the differences in mRNA expression levels between the wild-type and the homozygous <italic>Egr-1</italic> knockout mice both at the age of 30 days and 42 days. Genes were sorted after GO annotations. Genes that were significantly changed (with a FC &#x0003e; 1.5 and p-value &#x0003c; 0.05) in both the 30 days old mice and the 42 days old mice are shown in italics and are underlined. The gene that showed the highest differences in mRNA expression levels between the homozygous and the wild-type mice (<italic>Pcdhb9</italic> (shown in bold)) was further investigated using real-time PCR.</p></table-wrap-foot></table-wrap><table-wrap id="t3" position="float"><label>Table 3</label><caption><title>List of genes that were differentially expressed between wild-type and homozygous <italic>Egr-1</italic> knockout mice at the age of 42 days (<underline>wt/42 versus hm/42</underline>).</title></caption><table frame="hsides" rules="groups"><col width="84" span="1"/><col width="95" span="1"/><col width="241" span="1"/><col width="74" span="1"/><col width="65" span="1"/><col width="65" span="1"/><col width="65" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Affymetrix ID</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Gene symbol</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Gene title</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>FC (wt/p42 vs hm/p42)</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>p-value (wt/p42 vs hm/p42)</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>FC (wt/p30 vs hm/p30)</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>p-value (wt/p30 vs hm/p30)</bold></th></tr></thead><tbody><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Structural Molecule Activity (1)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1421811_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Thbs1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">thrombospondin 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;2.09<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0195<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.06<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.7630<hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Transporter Activity (4)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1458916_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Slc12a6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Solute carrier family 12, member 6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.61<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0076<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.08<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6697<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1457497_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Syt1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Synaptotagmin I<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.64<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0052<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.16<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6213<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1436044_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Scn7a</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>sodium channel, voltage-gated, type VII, alpha</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;1.89</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0003</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;1.28</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0383</underline></italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1415844_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Syt4</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>synaptotagmin IV</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;2.26</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0000</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;2.55</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0000</underline></italic><hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Enzyme Regulator Activity (7)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1444671_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Rasal2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RAS protein activator like 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.53<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0363<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.30<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.2962<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1446595_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Itsn2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">intersectin 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.53<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0182<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.26<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.4784<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1440347_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Arhgap10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Rho GTPase activating protein 10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.57<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0115<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.02<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9324<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1441386_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Rapgef1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Rap guanine nucleotide exchange factor 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.61<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0194<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.12<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.1515<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1445307_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Auts2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Autism susceptibility candidate 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.86<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0009<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.13<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.7187<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1442897_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2610024E20Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 2610024E20 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.50<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0219<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.39<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0095<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1416188_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Gm2a<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GM2 ganglioside activator protein<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.79<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0475<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.02<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8384<hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Molecular Transducer Activity (8)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1458469_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Cblb<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Casitas B-lineage lymphoma b<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.61<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0089<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.13<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6019<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1455967_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Sorbs1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">sorbin and SH3 domain containing 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.58<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0111<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.7148<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1445555_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Trpm3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Transient receptor potential cation channel, subfamily M, member 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.64<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0456<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.13<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5703<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1443279_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Nlk<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Nemo like kinase<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.55<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0307<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.09<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.7229<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1441498_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ptprd<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Protein tyrosine phosphatase, receptor type, D<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.57<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0499<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.12<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8303<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1441220_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Magi2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Membrane associated guanylate kinase, WW and PDZ domain containing 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.93<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0316<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8184<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1422723_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Stra6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">stimulated by retinoic acid gene 6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.59<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0205<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.22<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.3171<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1417205_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Kdelr2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.53<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0027<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.14<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.3870<hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Transcription Regulator Activity (13)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1441615_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Cbfa2t2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">core-binding factor, runt domain, alpha subunit 2, translocated to, 2 (human)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.53<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0280<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.02<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.92091<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1445914_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Nrf1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Nuclear respiratory factor 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.543<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0016<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.31<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5977<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1441140_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Rere<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Arginine glutamic acid dipeptide (RE) repeats<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.55<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0021<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.27<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.3524<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1456686_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Zfhx1a<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Zinc finger homeobox 1a<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.56<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0159<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.04<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.7871<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1439946_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Mef2c<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Myocyte enhancer factor 2C<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.62<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0041<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.14<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5653<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1458661_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Lcor<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ligand dependent nuclear receptor corepressor<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.63<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0265<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.04<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9105<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1446953_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Tcf4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Transcription factor 4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.63<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0097<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.03<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9567<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1445695_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Atxn1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ataxin 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.73<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0110<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.40<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.3692<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1417065_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Egr1</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>early growth response 1</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>1.79</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0004</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>1.99</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0000</underline></italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1443511_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Rora<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RAR-related orphan receptor alpha<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.96<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0294<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.18<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5929<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1436329_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Egr3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">early growth response 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.51<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0326<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.30<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.1831<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1443897_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ddit3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">DNA-damage inducible transcript 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.55<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0297<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.11<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6698<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1417930_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Nab2</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Ngfi-A binding protein 2</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;2.88</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0001</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;2.40</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0035</underline></italic><hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Catalytic Activity (17)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1458663_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Large<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Like-glycosyltransferase<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.50<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0298<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.37<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.2474<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1442813_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Dgki<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Diacylglycerol kinase, iota<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.53<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0448<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9982<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1435273_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Wars2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">tryptophanyl tRNA synthetase 2 (mitochondrial)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.53<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0008<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6011<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1443445_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Diap3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Diaphanous homolog 3 (Drosophila)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.61<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0162<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.32<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0682<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1442163_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Hace1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.64<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0043<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.11<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.7030<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1417024_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Hars</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>histidyl-tRNA synthetase</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>1.66</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0000</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>1.66</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0000</underline></italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1440066_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Smarcad1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.69<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0420<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.16<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.1397<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1445395_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Prkca<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Protein kinase C, alpha<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.69<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0030<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.04<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9369<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1438583_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ern1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Endoplasmic reticulum (ER) to nucleus signaling 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.71<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0264<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.50<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0969<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1446412_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Wwox<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">WW domain-containing oxidoreductase<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.76<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0152<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.104<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6550<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1445188_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Gphn<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Gephyrin<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.80<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0010<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.13<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.7227<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1455905_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2610507B11Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 2610507B11 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.50<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0435<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.15<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.3423<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1430177_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ube2b<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ubiquitin-conjugating enzyme E2B, RAD6 homology (S. cerevisiae)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.52<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0099<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.33<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.2071<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1439540_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">March2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">membrane-associated ring finger (C3HC4) 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.52<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0115<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.40<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0493<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1416613_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Cyp1b1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">cytochrome P450, family 1, subfamily b, polypeptide 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.54<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0402<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.19<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.3717<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1421024_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Agpat1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1-acylglycerol-3-phosphate O-acyltransferase 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.55<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0048<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.02<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8328<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1439843_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Camk4</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>calcium/calmodulin-dependent protein kinase IV</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;1.95</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0006</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;2.19</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0000</underline></italic><hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Binding (30)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1441567_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Myo9a<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Myosin IXa<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.50<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0249<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.07<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8016<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1447381_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Cpsf6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Cleavage and polyadenylation specific factor 6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.51<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0298<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.12<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5466<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1456773_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Nupl2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">nucleoporin like 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.51<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0362<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.07<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6814<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1441373_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Msi2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Musashi homolog 2 (Drosophila)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.53<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0046<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.14<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6634<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1436382_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Zbtb12<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">zinc finger and BTB domain containing 12<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.54<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0359<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.18<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.1262<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1456303_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Phf14<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">PHD finger protein 14<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.54<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0178<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.07<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8732<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1443199_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Lrch3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Leucine-rich repeats and calponin homology (CH) domain containing 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.55<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0347<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.29<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.2964<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1443337_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Grip1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Glutamate receptor interacting protein 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.55<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0332<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.30<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5147<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1447615_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Fmn1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Formin 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.55<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0082<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.19<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6470<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1455893_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Rspo2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">R-spondin 2 homolog (<italic>Xenopus laevis</italic>)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.55<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0419<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.09<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5464<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1446279_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Negr1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Neuronal growth regulator 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.58<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0314<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.02<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9288<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1445329_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Dtnb<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">dystrobrevin, beta<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.58<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0214<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.07<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.7944<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1444384_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Jazf1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">JAZF zinc finger 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.58<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0358<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.34<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.2980<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1439123_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Phf21a<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">PHD finger protein 21A<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.60<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0102<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.14<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6756<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1441769_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Arl15<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ADP-ribosylation factor-like 15<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.61<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0200<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.03<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9351<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1442411_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Glcci1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Glucocorticoid induced transcript 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.63<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0068<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.16<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6206<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1440551_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Dnajc1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">DnaJ (Hsp40) homolog, subfamily C, member 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.66<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0280<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.21<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5996<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1440543_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">D930036F22Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA D930036F22 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.66<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0428<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.02<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9482<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1443315_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Dmd</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Dystrophin</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>1.66</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0103</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;2.45</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0492</underline></italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1456351_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Brd8</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>bromodomain containing 8</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>1.66</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0005</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>1.67</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0003</underline></italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1446481_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Apbb2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Amyloid beta (A4) precursor protein-binding, family B, member 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.68<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0279<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.06<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8385<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1458263_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Cugbp2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CUG triplet repeat, RNA binding protein 2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.74<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0041<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8176<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1440067_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ncam1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Neural cell adhesion molecule 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.75<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0171<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.03<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9102<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1444488_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Cadps<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ca&#x0003c;2+&#x0003e;dependent activator protein for secretion<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.76<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0054<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.01<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9801<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1441330_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Crb1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">crumbs homolog 1 (Drosophila)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.99<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0214<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.12<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.4163<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1429239_a_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Stard4</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>StAR-related lipid transfer (START) domain containing 4</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>2.18</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.001991</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>1.79</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0295</underline></italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1451692_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Tmco6</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>transmembrane and coiled-coil domains 6</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>2.73</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0002</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>4.10</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.000</underline></italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1449548_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Efnb2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ephrin B2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.58<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0436<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.05<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8291<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1449527_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>Pcdhb7</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>protocadherin beta 7</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;1.64</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0016</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;1.58</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0155</underline></italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>1422640_at</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>Pcdhb9</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>protocadherin beta 9</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>&#x02212;17.48</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>0.0000</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>&#x02212;14.34</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>0.0000</bold><hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Unknown (43)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1454397_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">4632418H02Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 4632418H02 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.50<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0066<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.05<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8725<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1432713_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">6430709C05Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 6430709C05 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.51<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0031<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.05<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8923<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1442509_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Evi5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ecotropic viral integration site 5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.52<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0156<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.03<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9005<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1429900_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">5330406M23Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 5330406M23 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.52<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0119<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.12<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8002<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1444651_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">LOC553089<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">hypothetical LOC553089<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.53<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0230<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.42<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.3710<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1459409_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ccdc109a<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">coiled-coil domain containing 109A<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.53<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0337<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.01<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9616<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1440570_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Lhfpl3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Lipoma HMGIC fusion partner-like 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.53<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.010572<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.29<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.4440<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1430195_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2810043O03Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 2810043O03 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.54<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0153<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.16<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.7564<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1438788_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">D5Wsu152e<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">DNA segment, Chr 5, Wayne State University 152<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.54<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0060<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.15<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.7128<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1444137_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">A430108G06Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA A430108G06 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.54<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0017<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.03<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8671<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1457781_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Kcnq1ot1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">KCNQ1 overlapping transcript 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.54<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0013<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9993<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1430096_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2900017F05Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 2900017F05 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.56<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0160<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.14<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5974<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1443088_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">9930031P18Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 9930031P18 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.56<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0026<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.16<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.7326<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1458706_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2610035D17Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 2610035D17 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.56<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0048<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.08<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5992<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1453706_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2900042A17Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 2900042A17 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.57<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0272<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.02<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9373<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1443489_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Vps13b<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Vacuolar protein sorting 13B (yeast)<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.57<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0012<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.01<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9575<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1440604_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">8030494B02Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Riken cDNA 8030494B02 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.57<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0255<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.35<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.2507<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1444445_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">C77648<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">expressed sequence C77648<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.57<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0475<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6343<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1433837_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">8430408G22Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 8430408G22 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.57<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0226<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9943<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1457508_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">C430003N24Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA C430003N24 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.60<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0022<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.34<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.3974<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1454558_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">5430416B10Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 5430416B10 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.60<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0256<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.07<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8665<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1440892_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">BC017647<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CDNA sequence BC017647<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.63<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0403<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.06<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8572<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1441467_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Tspan5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Tetraspanin 5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.64<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0438<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6658<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1460101_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">NRXN3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Neurexin 3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.67<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0353<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.05<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9144<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1444109_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">C130009A20Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA C130009A20 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.67<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0109<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.01<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9683<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1454424_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2610040L17Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 2610040L17 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.68<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0058<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.06<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8692<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1433266_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2810416A17Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 2810416A17 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.66<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0005<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.14<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.7660<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1442561_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Mamdc1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">MAM domain containing 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.69<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0202<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.06<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9040<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1453906_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Med13l<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">mediator complex subunit 13-like<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.69<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0010<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.02<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9415<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1443201_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Gpc6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Glypican 6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.70<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0288<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.20<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6594<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1458309_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Dip2c<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">disco-interacting protein 2 homolog C<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.73<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0250<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.04<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8794<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1458505_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">LOC552901<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">hypothetical LOC552901<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.75<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0206<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.20<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5693<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1429977_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">9030425L15Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 9030425L15 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.76<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0068<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.07<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9202<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1440513_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">C80258<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">expressed sequence C80258<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.79<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0100<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.20<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.6384<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1429870_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">C630040K21Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA C630040K21 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.79<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0029<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.01<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9797<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1446102_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">D9Ertd292e<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">DNA segment, Chr 9, ERATO Doi 292, expressed<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.81<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0028<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.23<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.2711<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1458779_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">8030445P17Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 8030445P17 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.83<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0154<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.17<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.763599<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1453897_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">C030014A21Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA C030014A21 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.85<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0025<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.46<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.265201<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1446606_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">LOC625175<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">hypothetical protein A630054D14<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.86<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0062<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.30<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.187229<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1432757_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">2900011L18Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA 2900011L18 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.90<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0232<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.30<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.623096<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1441231_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">LOC100042016<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">hypothetical protein LOC100042016<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.92<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0002<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.06<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.840764<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1439086_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">A930009L07Rik<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RIKEN cDNA A930009L07 gene<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.58<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0294<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.19<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.34015<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic><underline>1428909_at</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>A130040M12Rik</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>RIKEN cDNA A130040M12 gene</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;1.62</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0368</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>&#x02212;1.90</underline></italic><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic><underline>0.0001</underline></italic><hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><bold>Not Annotated (12)</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1446799_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.50<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0030<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.8224<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1443271_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.51<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0384<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.46<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.3101<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1441740_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.52<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0284<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.22<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.5593<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1443526_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.52<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0062<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.03<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9444<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1458077_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.55<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0148<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.01<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9758<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1445740_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.56<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0456<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9998<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1435409_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.61<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0220<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.59<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0878<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1439999_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.63<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0223<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.11<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.7133<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1443744_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.72<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0128<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.14<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.7148<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1444622_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.82<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0224<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.02<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9539<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1457479_at<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">1.95<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.0060<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.00<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">0.9815<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1459595_at</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">2.18</td><td valign="top" align="left" rowspan="1" colspan="1">0.0019</td><td valign="top" align="left" rowspan="1" colspan="1">1.07</td><td valign="top" align="left" rowspan="1" colspan="1">0.8169</td></tr></tbody></table><table-wrap-foot><p>Shown are Affymetrix ID, gene symbol, gene title, fold change (FC) and p-values that indicate the differences in gene expression levels between the wild-type and the homozygous <italic>Egr-1</italic> knockout mice both at the age of 42 days and 30 days. Genes were sorted after GO annotations. Genes that were significantly changed (with a FC &#x0003e; 1.5 and p-value &#x0003c; 0.05) in both the 42 days old mice and the 30 days old mice are shown in italics and are underlined. The gene that showed the highest differences in mRNA expression levels between the homozygous and the wild-type mice (<italic>Pcdhb9</italic> [shown in bold]) was further investigated using real-time PCR.</p></table-wrap-foot></table-wrap><p>Thirteen genes showed up in both lists (shown in italics and underlined in both <xref ref-type="table" rid="t2">Table 2</xref> and <xref ref-type="table" rid="t3">Table 3</xref>) and except for one gene (dystrophin (<italic>DMD</italic>)), the regulation of mRNA expression levels was in the same direction at both 30 days and 42 days. The gene that showed the highest difference in mRNA expression levels (<italic>Pcdhb9,</italic> shown in bold in <xref ref-type="table" rid="t2">Table 2</xref> and <xref ref-type="table" rid="t3">Table 3</xref>), was further studied using semiquantitative real-time RT&#x02013;PCR.</p></sec><sec><title>Pathway analyses</title><p>Data obtained by comparison of the mRNA expression patterns in the homozygous <italic>Egr-1</italic> knockout mice between the age of 30 days and 42 days (hm/30 versus hm/42, see <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/v15/a288/app-2.xls">Appendix 2</ext-link>, 215 genes) were analyzed using the software &#x0201c;Ingenuity Pathway Analysis.&#x0201d; Several networks were identified that could be involved in retinal signaling. We chose three networks that appeared different in the homozygous <italic>Egr-1</italic> knockout mice (see <xref ref-type="fig" rid="f1">Figure 1A-C</xref>) to find candidates for validation by real-time RT&#x02013;PCR. Networks proposed by the software were common signaling pathways. All genes that were found to be differently expressed in the knockout mice are indicated by filled gray symbols in <xref ref-type="fig" rid="f1">Figure 1</xref>. Genes labeled as open symbols represent intermediate metabolic steps, determined from the current literature by the software. Molecules represented in network A (<xref ref-type="fig" rid="f1">Figure 1A</xref>) are regulated by mitogen-activated protein kinases (MAPK), which respond to a variety of extracellular stimuli and regulate various cellular activities, such as gene expression, mitosis, differentiation, and cell survival/apoptosis [<xref ref-type="bibr" rid="r34">34</xref>]. These kinases seem to be effector proteins in network B (<xref ref-type="fig" rid="f1">Figure 1B</xref>) as well, together with insulin, the early response transcription factor activator-protein 1 (Ap1) and another ubiquitous transcription factor, nuclear factor-kappa B (NfkB). The central molecules in network C (<xref ref-type="fig" rid="f1">Figure 1C</xref>) are retinoic acid, vascular endothelial growth factor A (Vegf-A), V-fos FBJ murine osteosarcoma viral oncogene homolog (Fos) and beta-estradiol.</p><p>Furthermore, several pathways were identified in both the wild-type and the homozygous knockout mice (wt/30 versus wt/42 and hm/30 versus hm/42, shown in <xref ref-type="table" rid="t4">Table 4</xref>). The lack of Egr-1 seems to affect a variety of pathways and many fundamental pathways are part of this list (e.g., synaptic long-term depression and potentiation, PDGF- and chemokine signaling, and others).</p><table-wrap id="t4" position="float"><label>Table 4</label><caption><title>Pathways identified in the wild-type and the homozygous <italic>Egr-1</italic> knockout mice by Ingenuity Pathway Analysis Software (wt/30 versus wt/42 and hm/30 versus hm/42).</title></caption><table frame="hsides" rules="groups"><col width="169" span="1"/><col width="295" span="1"/><thead><tr><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1"><bold>Pathways detected in wild-type mice (30 days versus 42 days, 54 differentially expressed genes):</bold></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Pathway</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>Molecules</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Arachidonic Acid Metabolism<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Gpx3, Cyp2d6, Ptgds</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Acute Phase Response Signaling<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Ttr, Tf, A2m</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">FXR/RXR Activation<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Pon1, Cyp27a1</italic><hr/></td></tr><tr><td colspan="2" valign="top" align="left" scope="col" rowspan="1"><bold>Pathways detected in Egr-1 knockout-mice (30 days versus 42 days, 215 differentially expressed genes):</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>Pathway</bold><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>Molecules</bold><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Synaptic Long-term Depression<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Plcb4, Itpr2, Igf1r, Gna13, Prkca, Prkcb1</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Synaptic Long-term Potentiation<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Plcb4, Itpr2, Atf2, Prkca, Prkcb1</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Huntington's Disease Signaling<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Gnb1, Plcb4, Igf1r, Zdhhc17, Atf2, Prkca, Prkcb1</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">PDGF Signaling<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Crkl, Abl1, Prkca, Prkcb1</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chemokine Signaling<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Plcb4, Ppp1r12b, Prkca, Prkcb1</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">VDR/RXR Activation<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Igfbp3, Ncoa1, Prkca, Prkcb1</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">FGF Signaling<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Crkl, Fgf11, Atf2, Prkca</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ephrin Receptor Signaling<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Gnb1, Crkl, Abl1, Gna13, Atf2, Rapgef1</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Axonal Guidance Signaling<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Gnb1, Plcb4, Pfn1, Crkl, Abl1, Gna13, Prkca, Prkcb1</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Lysine Degradation<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Setdb1, Nsd1, Ogdh</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Actin Cytoskeleton Signaling<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Pfn1, Diaph3, Crkl, Ppp1r12b, Fgf11, Gna13</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Circadian Rhythm Signaling<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Arntl, Atf2</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">G-Protein Coupled Receptor Signaling<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Pde8a, Plcb4, Atf2, Prkca, Prkcb1</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Integrin Signaling<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Tspan5, Crkl, Ppp1r12b, Abl1, Rapgef1</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Neuregulin Signaling<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Crkl, Prkca, Prkcb1</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">SAPK/JNK Signaling<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Gnb1, Crkl, Gna13, Atf2</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">ERK/MAPK Signaling</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>Crkl, Atf2, Rapgef1, Prkca, Prkcb1</italic></td></tr></tbody></table><table-wrap-foot><p>Shown are the descriptions of the pathways and the molecules involved in both the wild-type and the homozygous <italic>Egr-1</italic> knockout mice that changed their mRNA expression patterns over the investigated period of time (p30 versus p42) based on Ingenuity Pathway Analysis Software.</p></table-wrap-foot></table-wrap></sec><sec><title>Real-time RT&#x02013;PCR</title><p>Based on the three networks identified by Ingenuity Pathways Analysis Software (hm/30 versus hm/42, <xref ref-type="fig" rid="f1">Figure 1A-C</xref>), nine genes were chosen for validation of their changes in mRNA expression by real-time RT&#x02013;PCR, with three genes present in each network. In addition, protocadherin-beta 9 (<italic>Pcdhb9</italic>), the gene that showed the highest fold-change in comparison between the wild-type and the knockout mice (wt/30 versus hm/30: 14-fold lower expressed in the homozygous mice and wt/42 versus hm/42: 17-fold lower expressed) was tested with real-time RT&#x02013;PCR. The changes in mRNA expression levels of four of the genes could be validated (<xref ref-type="fig" rid="f2">Figure 2</xref>). Three of them were chosen based on network C (<italic>Narf</italic>, <italic>Ogdh</italic>, and <italic>Selenbp1</italic>) and the gene which showed the biggest difference in mRNA expression levels between wild-type and knockout mice, <italic>Pcdhb9</italic>, was also confirmed.</p><fig id="f2" fig-type="figure" position="float"><label>Figure 2</label><caption><p>Genes whose mRNA expression levels could be validated by real-time RT&#x02013;PCR. Mean relative expression values &#x000b1;SD (n=4) obtained by microarray analysis and mean normalized expression values obtained by real-time PCR (n=4). The p-values of the ANOVA's can be seen in the heading of the figures. The fold-changes and p-values (determined by un-paired Student's <italic>t</italic>-test as post-hoc analysis) were computed for the comparison between 30 days and 42 days old knockout- and wild-type mice (wt/30 versus wt/42 and hm/30 versus. hm/42) and are shown within the figures. Please note that in the case of <italic>Pcdhb9</italic>, the comparison is between the knockout and the wild-type mice at both ages (wt/30 versus. hm/30 and wt42 versus hm/42).</p></caption><graphic xlink:href="mv-v15-2720-f2"/></fig><p>The relative signal intensities obtained by microarray analysis (GC-RMA based, shown are the log transformed mean relative signal intensities &#x000b1;SD, n=4 each) of all four groups tested are shown in <xref ref-type="fig" rid="f2">Figure 2</xref>, upper graphs. The lower graphs shows the mean MNE-values &#x000b1;SD obtained by real-time RT&#x02013;PCR (n=4 each). The results of the ANOVA is indicated in the header of the figures for each gene and the fold-changes (FC) and p values (p) of the un-paired Student's <italic>t</italic>-tests as post-hoc tests for the comparisons between the 30 days old mice and the 42 days old mice are shown within the graphs.</p><p>Note that the comparison of the <italic>Pcdhb9</italic> expression is not between the two age groups, but between homozygous knockout mice and wild-type mice at both time points.</p><p>Nuclear prelamin A recognition factor (<italic>Narf</italic>) was lower expressed in the 42 days old homozygous mice, compared to the 30 days old mice in both the microarray analysis (hm/42 versus hm/30: &#x02212;1.65 fold, p&#x0003c;0.001) and the real-time PCR experiment (&#x02212;1.53 fold, p&#x0003c;0.05). The mRNA expression did not differ in the wild-type mice over time in either experiment.</p><p>Also Oxoglutarate dehydrogenase (<italic>Ogdh</italic>) was different only in the homozygous <italic>Egr-1</italic> knockout mice and showed no changes in mRNA expression levels over time in the wild-type. Post-hoc analysis confirmed that mRNA expression levels in the 30 day-old homozygous mice was significantly lower, compared to 42 day-old animals (hm/30 versus hm/42: 1.69-fold, with p&#x0003c;0.01 in the MA experiment and 1.51 fold with p&#x0003c;0.01 in the PCR experiment).</p><p>The mRNA expression levels of selenium binding protein 1 (<italic>Selenbp1</italic>) were higher in the 30 days old knockout mice, compared to the 42 days old homozygous mice (hm/42 versus hm/30: &#x02212;2.52 fold with p&#x0003c;0.001 in the MA experiment and &#x02212;2.23 fold with p&#x0003c;0.001 in the PCR experiment) and again, no such changes were observed in the wild-type.</p><p>In case of protocadherin-beta 9 (<italic>Pcdhb9</italic>), mRNA expression levels did not change with age, but were much lower in the knockout mice. Real-time PCR detected a fivefold decline in the expression of <italic>Pcdhb9</italic> in knockout mice, both at p30 and at p42, whereas the microarray analysis determined an even larger decline (hm/30 versus wt/30: &#x02212;14 fold and hm/42 versus wt/42: &#x02212;17 fold, with p&#x0003c;0.001 each).</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Earlier studies suggested that <italic>Egr-1</italic> might play a role in eye growth regulation in chicks [<xref ref-type="bibr" rid="r13">13</xref>] and mice [<xref ref-type="bibr" rid="r20">20</xref>,<xref ref-type="bibr" rid="r35">35</xref>]. The current study attempted to determine which genes were differentially regulated in Egr-1 knockout mice at two different developmental stages. Since <italic>Egr-1</italic> knockout mice had longer eyes at age 42 days, compared to wild-type mice, but not at day 30, it was hoped that a correlation could be found between the expression of certain genes and changes in eye growth. Furthermore, it was hoped that some of the changes might occur that relate to genes or factors that are already known to be involved in the regulation of axial eye growth in animal models.</p><p>The analysis of retinal gene expression in homozygous <italic>Egr-1</italic> knockout mice and wild-type mice at different ages (p30 and p42) provided a huge amount of data. Depending on the comparisons (wild-type versus homozygous, 30 days versus 42 days), different information about gene expression were obtained and different conclusions could be drawn. The focus in this paper was on changes that occur in homozygous <italic>Egr-1</italic> knockout mice and wild-type mice between 30 and 42 days (wt/30 versus wt/42 and hm/30 versus hm/42). Some consistent changes in mRNA expression patterns were found in the <italic>Egr-1</italic> knockout mice compared to wild-type mice. Whether these genes are directly involved in the temporarily enhanced axial eye growth, or represent just epiphenomena, remains undefined and needs to be determined by further studies.</p><sec><title>Microarray</title><sec><title>Gene expression changes over time (p30 versus p42)</title><p>It was not surprising that in wild-type mice only 54 genes showed differential mRNA expression over time (wt/30 versus wt/42, see <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/v15/a288/app-1.pdf">Appendix 1</ext-link>), since the mouse retina is generally considered to be mature at the age of about p21 [<xref ref-type="bibr" rid="r36">36</xref>]. In the homozygous <italic>Egr-1</italic> knockout mice, 215 genes (roughly four times as many) were differently expressed (hm/30 versus hm/42, <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/v15/a288/app-2.xls">Appendix 2</ext-link>). Eight genes showed similar changes in mRNA expression in both the homozygous and the wild-type <italic>Egr-1</italic> knockout mice (shown in italics and underlined in <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/v15/a288/app-1.pdf">Appendix 1</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/v15/a288/app-2.xls">Appendix 2</ext-link>). They likely encode for proteins that are involved in normal retinal function and are not related to the abnormal ocular growth in the knockout mice.</p><p>The average mean fold-changes in this study were 1.48&#x000b1;0.41, which is in line with findings from other microarray studies [<xref ref-type="bibr" rid="r16">16</xref>,<xref ref-type="bibr" rid="r19">19</xref>,<xref ref-type="bibr" rid="r37">37</xref>,<xref ref-type="bibr" rid="r38">38</xref>]. It has to be kept in mind that global gene expression measurements in a heterogeneous tissue like the retina are difficult to interpret since large changes in mRNA expression in a subset of cells might be obscured by changes in the opposite direction in a different, perhaps even more abundant population of cells. For the same reason, large changes in mRNA expression in a rare cell type might go unnoticed because they generate only a small fraction of the total mRNA. In the future, quantitative immunohistochemistry might help to detect changes in gene products which are localized to certain cells types.</p></sec></sec><sec><title>Differences in gene expression in Egr-1 knockout mice and their wild-type</title><p>Thirteen genes were differentially expressed in knockout mice, compared to wild-type, at both ages tested (<xref ref-type="table" rid="t2">Table 2</xref> and <xref ref-type="table" rid="t3">Table 3</xref>: genes are shown in italics and underlined). Except for dystrophin (<italic>DMD</italic>), the regulation of those genes was in the same direction at both ages. These genes are therefore most probably target genes of Egr-1 and are not directly related to the developmental changes observed in these mice. Nevertheless, these thirteen genes are of interest because they were not previously described as possible targets for the Egr-1 protein. Still, whether the interaction with the Egr-1 protein is direct or indirect, has yet to be experimentally validated using other techniques like chromatin immunoprecipitation. The <italic>Egr-1</italic> knockout mice used in our study contain several in-frame stop codons in the <italic>Egr-1</italic> coding sequence, upstream of the zinc finger DNA binding domain. Parts of the mRNA sequence of <italic>Egr-1</italic> can therefore still be transcribed but the stop-codons lead to the functional elimination of the protein Egr1. The truncated <italic>Egr-1</italic> mRNAs can still bind to the microarray. Upregulation of <italic>Egr-1</italic> mRNA itself in the knockout mice can be explained by the fact that Egr-1 can suppress its own expression, as has been shown in tissue culture [<xref ref-type="bibr" rid="r39">39</xref>]. A negative feedback mechanism has already been described elsewhere and can be seen for <italic>Nab2</italic> (Ngfi-A-binding protein-2) [<xref ref-type="bibr" rid="r40">40</xref>]. This protein was massively downregulated in <italic>Egr-1</italic> knockout mice and is assumed to be a major regulator of Egr-1 function, since it is induced by the same stimuli that induce Egr-1. Dystrophin (<italic>DMD</italic>) mRNA expression was lower at p30 in the homozygous mice, compared to the wild-type mice, and higher at p42. An enhanced DMD content may therefore be correlated with enhanced axial eye growth. DMD is a plasma membrane-associated cytoskeletal protein of the spectrin superfamily and its absence or functional deficiency is the cause of several types of muscular dystrophies in humans. In some of these patients, retinal function is affected as well, as reflected in a reduced b-wave in the electroretinograms (ERG). DMD isoforms have been localized to M&#x000fc;ller cells and photoreceptor terminals, so the abnormality in the ERGs is most likely due to a disturbance of neurotransmission between photoreceptors and ON-bipolar cells [<xref ref-type="bibr" rid="r41">41</xref>]. Interestingly, the lack of the dystrophin isoform Dp71 leads to impaired clustering of two M&#x000fc;ller glia cell proteins in mice, namely the inwardly rectifying potassium channel Kir4.1 and the water pore aquaporin 4 (AQP4) [<xref ref-type="bibr" rid="r42">42</xref>]. Both Kir4.1 and AQP4 have already been implicated in the development of myopia and their role as a conduit for movement of retinal fluid into the vitreous was suggested [<xref ref-type="bibr" rid="r43">43</xref>,<xref ref-type="bibr" rid="r44">44</xref>].</p><p>Protocadherin beta 9 (<italic>Pcdhb9</italic>) was the most heavily regulated gene in this study (wt/30 versus hm/30: 14-fold downregulated and wt/42 versus hm/42: 17-fold downregulated in the homozygous <italic>Egr-1</italic> knockout mice). Protocadherins are calcium-dependent cell&#x02013;cell adhesion molecules. Their specific functions are unknown, but they most likely play a critical role in the establishment and function of specific cell-cell neural connections [<xref ref-type="bibr" rid="r45">45</xref>]. The massive downregulation of this gene suggests a tight control, either directly by Egr-1, or indirectly by other Egr-1-regulated genes.</p></sec><sec><title>Ingenuity pathway analysis</title><p>The list of genes that were differentially expressed in the <italic>Egr-1</italic> knockout mice between the age of 30 and 42 days (hm/30 versus hm/42) was analyzed using Ingenuity Pathway Analysis Software. Many ubiquitous signaling pathways in the retina seem to be involved. Therefore, it is difficult to define those genes that are responsible for the development of the relative myopia in the 42-day-old <italic>Egr-1</italic> knockout mice. As can be seen in <xref ref-type="fig" rid="f1">Figures 1A-C</xref>, genes that showed altered mRNA expression in this study were not the key regulators in the functional networks proposed by the software. As already mentioned above, these pathway schemes are based on known interactions between molecules. They provide only suggestions for possible interactions. Involvement of the intermediate proteins and co-factors in these pathways is, therefore, possible but not proven. Furthermore, since the changes in mRNA expression levels of any gene chosen from network A and B could not be validated in all cases, it is difficult to speculate about the involvement of these networks as illustrated in <xref ref-type="fig" rid="f1">Figure 1</xref>.</p><p>The only data available on visual function in <italic>Egr-1</italic> knockout mice are from optomotor experiments. They did not show any differences in contrast sensitivity or spatial resolution to the wild-type [<xref ref-type="bibr" rid="r20">20</xref>]. Interestingly, the lack of Egr-1 does not seem to affect other sensory systems in the mouse, like the auditory system. Auditory function was studied by evoked brainstem responses (ABR) and otoacoustic emissions (DPOAE), but no differences were found between wild-types and knockout mice (Dr. Lukas R&#x000fc;ttiger, Tuebingen Hearing Research Centre [THRC], Tuebingen, Germany, personal communication 2008). Therefore the function of Egr-1 in the regulation of axial eye growth seems to be quite specific despite the fact that common signaling pathways were affected.</p></sec><sec><title>Real-time RT&#x02013;PCR</title><sec><title>Validation of genes</title><p>The mRNA expression levels of four out of the ten tested genes could be validated (<xref ref-type="fig" rid="f2">Figure 2</xref>). To be able to compare the relative expression levels as determined by microarray analysis (MA) and real-time PCR (PCR) easily, <xref ref-type="fig" rid="f2">Figure 2</xref> shows the results of MA and PCR experiments separately for each gene. Non-validated genes are not represented in this figure. The fold-changes determined by PCR and MA of <italic>Narf</italic>, <italic>Ogdh</italic>, and <italic>Selenbp1</italic> were very similar whereas for <italic>Pcdhb9</italic>, the magnitude of changes was severely overestimated by MA. Considering this fact, the involvement of network A and B is more questionable, since none of the genes tested with real-time PCR could be validated. On the other hand, only three genes were tested in each network, and others which would have been validated upon testing might have been overlooked. Our primers were designed to bind to the same part of the sequence that was detected by the oligonucleotide probes on the Affymetrix chip (to avoid detection of different isoforms) and should have been appropriate to validate the microarray results. The applied false-discovery-rate of 5% thus does not seem to reflect the true errors that are unavoidable in this technique. These observations confirm that validation of the results of microarray analyses by other techniques (in this case semiquantitative real-time RT&#x02013;PCR) should be mandatory.</p></sec></sec><sec><title>Genes whose transcription could be validated</title><p>The functions of the three genes which could be validated with real-time PCR are described in more detail below:</p><sec><title>Narf</title><p>The expression of Nuclear prelamin A recognition factor was found to be lowest in the 42 days old knockout mice. Prenylation and methylation occurs at the C-terminal end of proteins and was initially believed to be important only for membrane attachment. However, another role for prenylation appears to be the mediation of protein&#x02013;protein interactions [<xref ref-type="bibr" rid="r46">46</xref>]. The only nuclear proteins known to be prenylated in mammalian cells are prelamin A- and B-type lamins. Lamins are fibrous proteins providing structural function and transcriptional regulation in the cell nucleus, but the cellular role of both the prenylated prelamin A precursor and Narf, which is known to bind to the farnesylated prelamin A, is unknown and its role in the retina is unclear.</p></sec><sec><title>Ogdh</title><p>Oxoglutarate dehydrogenase mRNA expression was significantly enhanced in 42-day-old knockout mice. Ogdh is a mitochondrial enzyme complex, comprising of three different subunits (Ogdh, Dld, Dlst) that converts 2-oxoglutatate into succinyl-CoA and carbon dioxide in the Krebs cycle. Its reduction in patients with Alzheimer disease suggests an altered metabolism of the nervous tissue [<xref ref-type="bibr" rid="r47">47</xref>]. Unfortunately, no information is available yet for the role of this enzyme in the retina, but it could well be that the changes in mRNA expression of this gene reflects changes in the metabolic rate of retinal cells in the homozygous <italic>Egr-1</italic> knockout mice.</p></sec><sec><title>Selenbp1</title><p>Egr-1 knockout mice showed a high expression of Selenbp1 at the age of 30 days, with a subsequent decline. Selenium binding protein has been shown in several studies to be downregulated in cancer [<xref ref-type="bibr" rid="r48">48</xref>,<xref ref-type="bibr" rid="r49">49</xref>]. A protective effect of selenium in preventing macular degeneration has also been shown [<xref ref-type="bibr" rid="r50">50</xref>] and another selenium transporter (selenoprotein P) has been found to be upregulated in the retina of chicks that were treated with either positive or negative lenses [<xref ref-type="bibr" rid="r51">51</xref>]. Selenbp1 expression can be blocked by TGF-&#x003b2; in smooth muscle cells [<xref ref-type="bibr" rid="r52">52</xref>] and this protein (TGF-&#x003b2;) has already been implicated in myopia [<xref ref-type="bibr" rid="r53">53</xref>,<xref ref-type="bibr" rid="r54">54</xref>] and in the regulation of programmed cell death in the retina [<xref ref-type="bibr" rid="r55">55</xref>]. The role of selenium and its associated binding proteins in the retina of <italic>Egr-1</italic> knockout mice merits further investigation.</p></sec></sec><sec><title>Involvement of network C</title><p>Although the genes for which expression changes could be validated belong to this network, the involvement of the &#x0201c;key molecules&#x0201d; presented in <xref ref-type="fig" rid="f1">Figure 1C</xref> remains speculative. No mRNA expression changes of e.g., <italic>VEGF</italic>, <italic>cFos</italic>, or <italic>EGF</italic> were found in this study although oligonucleotides representing mRNAs of <italic>VEGF</italic>, <italic>cFos</italic>, <italic>EGF,</italic> and retinoic acid receptors are present on the Affymetrix chip used in this study. Obviously, the lack of functional Egr-1 protein did not affect mRNA expression levels of these genes.</p><p>Nevertheless, some of those molecules have already been proposed to play a role in the regulation of eye growth, or were shown to change in the retina in response to various optical stimuli [<xref ref-type="bibr" rid="r4">4</xref>-<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r13">13</xref>,<xref ref-type="bibr" rid="r16">16</xref>,<xref ref-type="bibr" rid="r56">56</xref>-<xref ref-type="bibr" rid="r62">62</xref>]. The fact that they seem to link several factors that were found to have changed mRNA expression levels in <italic>Egr-1</italic> knockout mice is in line with the idea that these molecules are involved in the regulation of eye growth.</p></sec><sec><title>Outlook</title><p>This study provided a list of genes that appear associated with Egr-1 signaling and/or altered eye growth in <italic>Egr-1</italic> knockout mice. It is difficult to define specific roles to those genes in eye growth in the <italic>Egr-1</italic> knockout mice. Analysis of possibly involved networks show that the lack of Egr-1 affects common pathways in the retina. Furthermore, other important factors (like cFos, VEGF, NfkB) may play a role as well, perhaps partially taking over the role of Egr-1 in the retina of <italic>Egr-1</italic> knockout mice. We believe that the microarray analysis is a powerful tool to detect NEW candidates, rather than to look at the &#x0201c;usual suspects.&#x0201d; It is, however, difficult to use the microarray technology in heterogeneous tissue like retina. There are now advanced methods available to focus on certain cell types (e.g., laser capture microdissection of fluorescent-activated cell sorting). Nevertheless, some interesting genes were found in this study. In addition, several direct or indirect target genes of Egr-1 could be identified, including the most prominently regulated gene protocadherin-beta 9. The list of differentially expressed genes is accessible online in the Gene Expression Omnibus (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE16974">GEO</ext-link>) Database and might be useful not only to researchers in the field of myopia.</p></sec></sec></body><back><app-group><app><title>Appendix 1. List of differentially expressed genes in the wild-type mice between p30 and p42 days (<underline>wt/30 versus wt/42</underline>).</title><p>To access the data, click or select the words &#x0201c;<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/v15/a288/app-1.pdf">Appendix 1</ext-link>.&#x0201d; This will initiate the download of a (pdf) archive that contains the file. Affymetrix ID, gene symbol, gene title, fold change (FC) and p-values of both the wild-type mice and the homozygous <italic>Egr-1</italic> knockout mice are shown. Genes were sorted after GO annotations. Genes that were significantly changed (with a FC &#x0003e; 1.5 and p-value &#x0003c; 0.05) in both the wild-type mice and the homozygous <italic>Egr-1</italic> knockout mice are shown in italics and are underlined.</p></app><app><title>Appendix 2. List of genes that were differentially expressed in the homozygous <italic>Egr-1</italic> knockout mice between p30 and p42 (<underline>hm/30 versus hm/42</underline>).</title><p>To access the data, click or select the words &#x0201c;<ext-link ext-link-type="uri" xlink:href="http://www.molvis.org/molvis/v15/a288/app-2.xls">Appendix 2</ext-link>.&#x0201d; This will initiate the download of an Excel (.xls) file that contains the file.Affymetrix ID, gene symbol, gene title, fold change (FC), and p-values of both the homozygous <italic>Egr-1</italic> knockout mice and the wild-type mice are shown. Genes were sorted after GO annotations. Genes that were significantly changed (with a FC &#x0003e;1.5 and p-value &#x0003c;0.05) in both the homozygous wild-type mice and the <italic>Egr-1</italic> knockout mice are shown in italics and are underlined. Genes that were chosen for real-time RT&#x02013;PCR validation are shown in bold.</p></app></app-group><ack><title>Acknowledgments</title><p>This study was supported by the German Research Foundation, DFG Sch518/13&#x02013;1. We thank Prof. Dr. Wissinger of the Molecular Genetics Department of the Opthalmic Research Institute in Tuebingen for sequencing of our samples.</p></ack><ref-list><title>Reference</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>RA</given-names></name><name><surname>Lin</surname><given-names>T</given-names></name><name><surname>Laties</surname><given-names>AM</given-names></name><name><surname>Iuvone</surname><given-names>PM</given-names></name></person-group><article-title>Retinal dopamine and form-deprivation myopia.</article-title><source>Proc Natl Acad Sci USA</source><year>1989</year><volume>86</volume><fpage>704</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">2911600</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iuvone</surname><given-names>PM</given-names></name><name><surname>Tigges</surname><given-names>M</given-names></name><name><surname>Stone</surname><given-names>RA</given-names></name><name><surname>Lambert</surname><given-names>S</given-names></name><name><surname>Laties</surname><given-names>AM</given-names></name></person-group><article-title>Effects of apomorphine, a dopamine receptor agonist, on ocular refraction and axial elongation in a primate model of myopia.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1991</year><volume>32</volume><fpage>1674</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">2016144</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>SS</given-names></name><name><surname>Sivak</surname><given-names>JG</given-names></name><name><surname>Callender</surname><given-names>MG</given-names></name><name><surname>Diehl-Jones</surname><given-names>B</given-names></name></person-group><article-title>Retinal dopamine and lens-induced refractive errors in chicks.</article-title><source>Curr Eye Res</source><year>1995</year><volume>14</volume><fpage>385</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">7648864</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seko</surname><given-names>Y</given-names></name><name><surname>Shimizu</surname><given-names>M</given-names></name><name><surname>Tokoro</surname><given-names>T</given-names></name></person-group><article-title>Retinoic acid increases in the retina of the chick with form deprivation myopia.</article-title><source>Ophthalmic Res</source><year>1998</year><volume>30</volume><fpage>361</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9731117</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bitzer</surname><given-names>M</given-names></name><name><surname>Feldkaemper</surname><given-names>MP</given-names></name><name><surname>Schaeffel</surname><given-names>F</given-names></name></person-group><article-title>Visually induced changes in components of the retinoic acid system in fundal layers of the chick.</article-title><source>Exp Eye Res</source><year>2000</year><volume>70</volume><fpage>97</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">10644425</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mertz</surname><given-names>JR</given-names></name><name><surname>Wallman</surname><given-names>J</given-names></name></person-group><article-title>Choroidal retinoic acid synthesis: a possible mediator between refractive error and compensatory eye growth.</article-title><source>Exp Eye Res</source><year>2000</year><volume>70</volume><fpage>519</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">10866000</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname><given-names>S</given-names></name><name><surname>Honda</surname><given-names>S</given-names></name><name><surname>Sekiya</surname><given-names>Y</given-names></name><name><surname>Yamasaki</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Saijoh</surname><given-names>K</given-names></name></person-group><article-title>Differential expression of nitric oxide synthase isoforms in form-deprived chick eyes.</article-title><source>Curr Eye Res</source><year>1998</year><volume>17</volume><fpage>586</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">9663848</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nickla</surname><given-names>DL</given-names></name><name><surname>Wildsoet</surname><given-names>CF</given-names></name></person-group><article-title>The effect of the nonspecific nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester on the choroidal compensatory response to myopic defocus in chickens.</article-title><source>Optom Vis Sci</source><year>2004</year><volume>81</volume><fpage>111</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15127930</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nickla</surname><given-names>DL</given-names></name><name><surname>Wilken</surname><given-names>E</given-names></name><name><surname>Lytle</surname><given-names>G</given-names></name><name><surname>Yom</surname><given-names>S</given-names></name><name><surname>Mertz</surname><given-names>J</given-names></name></person-group><article-title>Inhibiting the transient choroidal thickening response using the nitric oxide synthase inhibitor l-NAME prevents the ameliorative effects of visual experience on ocular growth in two different visual paradigms.</article-title><source>Exp Eye Res</source><year>2006</year><volume>83</volume><fpage>456</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">16635488</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>RA</given-names></name><name><surname>Laties</surname><given-names>AM</given-names></name><name><surname>Raviola</surname><given-names>E</given-names></name><name><surname>Wiesel</surname><given-names>TN</given-names></name></person-group><article-title>Increase in retinal vasoactive intestinal polypeptide after eyelid fusion in primates.</article-title><source>Proc Natl Acad Sci USA</source><year>1988</year><volume>85</volume><fpage>257</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">2448769</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raviola</surname><given-names>E</given-names></name><name><surname>Wiesel</surname><given-names>TN</given-names></name></person-group><article-title>Neural control of eye growth and experimental myopia in primates.</article-title><source>Ciba Found Symp</source><year>1990</year><volume>155</volume><fpage>22</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">2088678</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seltner</surname><given-names>RL</given-names></name><name><surname>Stell</surname><given-names>WK</given-names></name></person-group><article-title>The effect of vasoactive intestinal peptide on development of form deprivation myopia in the chick: a pharmacological and immunocytochemical study.</article-title><source>Vision Res</source><year>1995</year><volume>35</volume><fpage>1265</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">7610586</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>AJ</given-names></name><name><surname>McGuire</surname><given-names>JJ</given-names></name><name><surname>Schaeffel</surname><given-names>F</given-names></name><name><surname>Stell</surname><given-names>WK</given-names></name></person-group><article-title>Light- and focus-dependent expression of the transcription factor ZENK in the chick retina.</article-title><source>Nat Neurosci</source><year>1999</year><volume>2</volume><fpage>706</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">10412059</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bitzer</surname><given-names>M</given-names></name><name><surname>Schaeffel</surname><given-names>F</given-names></name></person-group><article-title>Defocus-induced changes in ZENK expression in the chicken retina.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2002</year><volume>43</volume><fpage>246</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">11773038</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname><given-names>AJ</given-names></name><name><surname>Ritchey</surname><given-names>ER</given-names></name><name><surname>Scott</surname><given-names>MA</given-names></name><name><surname>Wynne</surname><given-names>A</given-names></name></person-group><article-title>Bullwhip neurons in the retina regulate the size and shape of the eye.</article-title><source>Dev Biol</source><year>2008</year><volume>317</volume><fpage>196</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">18358467</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname><given-names>C</given-names></name><name><surname>Schaeffel</surname><given-names>F</given-names></name><name><surname>Feldkaemper</surname><given-names>MP</given-names></name></person-group><article-title>A microarray analysis of retinal transcripts that are controlled by image contrast in mice.</article-title><source>Mol Vis</source><year>2007</year><volume>13</volume><fpage>920</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">17653032</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashby</surname><given-names>R</given-names></name><name><surname>McCarthy</surname><given-names>CS</given-names></name><name><surname>Maleszka</surname><given-names>R</given-names></name><name><surname>Megaw</surname><given-names>P</given-names></name><name><surname>Morgan</surname><given-names>IG</given-names></name></person-group><article-title>A muscarinic cholinergic antagonist and a dopamine agonist rapidly increase ZENK mRNA expression in the form-deprived chicken retina.</article-title><source>Exp Eye Res</source><year>2007</year><volume>85</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">17498696</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="thesis">Ashby RS. Molecular control of eye growth: A candidate gene approach [dissertation]. Canberra (AU): The Australian National University 2007.</mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schippert</surname><given-names>R</given-names></name><name><surname>Schaeffel</surname><given-names>F</given-names></name><name><surname>Feldkaemper</surname><given-names>MP</given-names></name></person-group><article-title>Microarray analysis of retinal gene expression in chicks during imposed myopic defocus.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>1589</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">18769560</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schippert</surname><given-names>R</given-names></name><name><surname>Burkhardt</surname><given-names>E</given-names></name><name><surname>Feldkaemper</surname><given-names>MP</given-names></name><name><surname>Schaeffel</surname><given-names>F</given-names></name></person-group><article-title>Relative axial myopia in Egr-1 (ZENK) knockout mice.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2007</year><volume>48</volume><fpage>11</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17197510</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virolle</surname><given-names>T</given-names></name><name><surname>Krones-Herzig</surname><given-names>A</given-names></name><name><surname>Baron</surname><given-names>V</given-names></name><name><surname>De Gregorio</surname><given-names>G</given-names></name><name><surname>Adamson</surname><given-names>ED</given-names></name><name><surname>Mercola</surname><given-names>D</given-names></name></person-group><article-title>Egr1 promotes growth and survival of prostate cancer cells. Identification of novel Egr1 target genes.</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>11802</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">12556466</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JL</given-names></name><name><surname>Everitt</surname><given-names>BJ</given-names></name><name><surname>Thomas</surname><given-names>KL</given-names></name></person-group><article-title>Independent cellular processes for hippocampal memory consolidation and reconsolidation.</article-title><source>Science</source><year>2004</year><volume>304</volume><fpage>839</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">15073322</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>M</given-names></name></person-group><article-title>Egr-1 target genes in human endothelial cells identified by microarray analysis.</article-title><source>Gene</source><year>2003</year><volume>315</volume><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">14557062</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>SJ</given-names></name><name><surname>Ning</surname><given-names>H</given-names></name><name><surname>Ishida</surname><given-names>W</given-names></name><name><surname>Sodin-Semrl</surname><given-names>S</given-names></name><name><surname>Takagawa</surname><given-names>S</given-names></name><name><surname>Mori</surname><given-names>Y</given-names></name><name><surname>Varga</surname><given-names>J</given-names></name></person-group><article-title>The early-immediate gene EGR-1 is induced by transforming growth factor-beta and mediates stimulation of collagen gene expression.</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>21183</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">16702209</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norton</surname><given-names>TT</given-names></name><name><surname>Rada</surname><given-names>JA</given-names></name></person-group><article-title>Reduced extracellular matrix in mammalian sclera with induced myopia.</article-title><source>Vision Res</source><year>1995</year><volume>35</volume><fpage>1271</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">7610587</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBrien</surname><given-names>NA</given-names></name><name><surname>Cornell</surname><given-names>LM</given-names></name><name><surname>Gentle</surname><given-names>A</given-names></name></person-group><article-title>Structural and ultrastructural changes to the sclera in a mammalian model of high myopia.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2001</year><volume>42</volume><fpage>2179</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">11527928</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegwart</surname><given-names>JT</given-names></name><name><surname>Norton</surname><given-names>TT</given-names></name></person-group><article-title>The time course of changes in mRNA levels in tree shrew sclera during induced myopia and recovery.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2002</year><volume>43</volume><fpage>2067</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">12091398</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khachigian</surname><given-names>LM</given-names></name><name><surname>Williams</surname><given-names>AJ</given-names></name><name><surname>Collins</surname><given-names>T</given-names></name></person-group><article-title>Interplay of Sp1 and Egr-1 in the proximal platelet-derived growth factor A-chain promoter in cultured vascular endothelial cells.</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>27679</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">7499234</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khachigian</surname><given-names>LM</given-names></name><name><surname>Lindner</surname><given-names>V</given-names></name><name><surname>Williams</surname><given-names>AJ</given-names></name><name><surname>Collins</surname><given-names>T</given-names></name></person-group><article-title>Egr-1-induced endothelial gene expression: a common theme in vascular injury.</article-title><source>Science</source><year>1996</year><volume>271</volume><fpage>1427</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">8596917</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biesiada</surname><given-names>E</given-names></name><name><surname>Razandi</surname><given-names>M</given-names></name><name><surname>Levin</surname><given-names>ER</given-names></name></person-group><article-title>Egr-1 activates basic fibroblast growth factor transcription. Mechanistic implications for astrocyte proliferation.</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><fpage>18576</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">8702507</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron</surname><given-names>V</given-names></name><name><surname>Adamson</surname><given-names>ED</given-names></name><name><surname>Calogero</surname><given-names>A</given-names></name><name><surname>Ragona</surname><given-names>G</given-names></name><name><surname>Mercola</surname><given-names>D</given-names></name></person-group><article-title>The transcription factor Egr-1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin.</article-title><source>Cancer Gene Ther</source><year>2006</year><volume>13</volume><fpage>115</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">16138117</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SL</given-names></name></person-group><article-title>Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1).</article-title><source>Science</source><year>1996</year><volume>273</volume><fpage>1219</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">8703054</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schippert</surname><given-names>R</given-names></name><name><surname>Brand</surname><given-names>C</given-names></name><name><surname>Schaeffel</surname><given-names>F</given-names></name><name><surname>Feldkaemper</surname><given-names>MP</given-names></name></person-group><article-title>Changes in scleral MMP-2, TIMP-2 and TGFbeta-2 mRNA expression after imposed myopic and hyperopic defocus in chickens.</article-title><source>Exp Eye Res</source><year>2006</year><volume>82</volume><fpage>710</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16289164</pub-id></mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearson</surname><given-names>G</given-names></name><name><surname>Robinson</surname><given-names>F</given-names></name><name><surname>Beers Gibson</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>BE</given-names></name><name><surname>Karandikar</surname><given-names>M</given-names></name><name><surname>Berman</surname><given-names>K</given-names></name><name><surname>Cobb</surname><given-names>MH</given-names></name></person-group><article-title>Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.</article-title><source>Endocr Rev</source><year>2001</year><volume>22</volume><fpage>153</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">11294822</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand</surname><given-names>C</given-names></name><name><surname>Burkhardt</surname><given-names>E</given-names></name><name><surname>Schaeffel</surname><given-names>F</given-names></name><name><surname>Choi</surname><given-names>JW</given-names></name><name><surname>Feldkaemper</surname><given-names>MP</given-names></name></person-group><article-title>Regulation of Egr-1, VIP, and Shh mRNA and Egr-1 protein in the mouse retina by light and image quality.</article-title><source>Mol Vis</source><year>2005</year><volume>11</volume><fpage>309</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">15889015</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="book">Smith RS, Kao WWY, John SWM. Ocular development. In: Smith RS, John SWM, Nishina PM, Sundberg JP, editors. Systematic Evaluation of the Mouse Eye: Anatomy, Pathology, and Biomethods. Boca Raton, London, New York, Washington, D.C.; CRC Press; 2002. p. 45&#x02013;63.</mixed-citation></ref><ref id="r37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGlinn</surname><given-names>AM</given-names></name><name><surname>Baldwin</surname><given-names>DA</given-names></name><name><surname>Tobias</surname><given-names>JW</given-names></name><name><surname>Budak</surname><given-names>MT</given-names></name><name><surname>Khurana</surname><given-names>TS</given-names></name><name><surname>Stone</surname><given-names>RA</given-names></name></person-group><article-title>Form-deprivation myopia in chick induces limited changes in retinal gene expression.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2007</year><volume>48</volume><fpage>3430</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17652709</pub-id></mixed-citation></ref><ref id="r38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rada</surname><given-names>JA</given-names></name><name><surname>Wiechmann</surname><given-names>AF</given-names></name></person-group><article-title>Ocular expression of avian thymic hormone: changes during the recovery from induced myopia.</article-title><source>Mol Vis</source><year>2009</year><volume>15</volume><fpage>778</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">19390653</pub-id></mixed-citation></ref><ref id="r39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Mahendran</surname><given-names>R</given-names></name><name><surname>Guy</surname><given-names>GR</given-names></name><name><surname>Tan</surname><given-names>YH</given-names></name></person-group><article-title>Detection and characterization of cellular EGR-1 binding to its recognition site.</article-title><source>J Biol Chem</source><year>1993</year><volume>268</volume><fpage>16949</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">8349585</pub-id></mixed-citation></ref><ref id="r40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumbrink</surname><given-names>J</given-names></name><name><surname>Gerlinger</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>JP</given-names></name></person-group><article-title>Egr-1 induces the expression of its corepressor nab2 by activation of the nab2 promoter thereby establishing a negative feedback loop.</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>42785</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">16260776</pub-id></mixed-citation></ref><ref id="r41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>F</given-names></name><name><surname>Drenckhahn</surname><given-names>D</given-names></name></person-group><article-title>Dystrophin in the retina.</article-title><source>Prog Neurobiol</source><year>1997</year><volume>53</volume><fpage>547</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">9421835</pub-id></mixed-citation></ref><ref id="r42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalloz</surname><given-names>C</given-names></name></person-group><article-title>Targeted inactivation of dystrophin gene product Dp71: phenotypic impact in mouse retina.</article-title><source>Hum Mol Genet</source><year>2003</year><volume>12</volume><fpage>1543</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">12812982</pub-id></mixed-citation></ref><ref id="r43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodyear</surname><given-names>MJ</given-names></name><name><surname>Junghans</surname><given-names>BM</given-names></name><name><surname>Giummarra</surname><given-names>L</given-names></name><name><surname>Murphy</surname><given-names>MJ</given-names></name><name><surname>Crewther</surname><given-names>DP</given-names></name><name><surname>Crewther</surname><given-names>SG</given-names></name></person-group><article-title>A role for aquaporin-4 during induction of form deprivation myopia in chick.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>298</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">18334967</pub-id></mixed-citation></ref><ref id="r44"><label>44</label><mixed-citation publication-type="confproc">Goodyear MJ, Crewther SG, Edwards MH, Junghans BM, Hazi A, Crewther DP. A role for aquaporin-4 (AQP4) channels and inward-rectifying potassium channels (Kir4.1) during refractive compensation to optical defocus. ARVO Annual Meeting; 2007 May 6&#x02013;10; Fort Lauderdale (FL).</mixed-citation></ref><ref id="r45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>M</given-names></name><name><surname>Kemler</surname><given-names>R</given-names></name></person-group><article-title>Protocadherins.</article-title><source>Curr Opin Cell Biol</source><year>2002</year><volume>14</volume><fpage>557</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">12231349</pub-id></mixed-citation></ref><ref id="r46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>CJ</given-names></name></person-group><article-title>Protein prenylation: a mediator of protein-protein interactions.</article-title><source>Science</source><year>1993</year><volume>259</volume><fpage>1865</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8456312</pub-id></mixed-citation></ref><ref id="r47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butterworth</surname><given-names>RF</given-names></name><name><surname>Besnard</surname><given-names>AM</given-names></name></person-group><article-title>Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease.</article-title><source>Metab Brain Dis</source><year>1990</year><volume>5</volume><fpage>179</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">2087217</pub-id></mixed-citation></ref><ref id="r48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>KC</given-names></name></person-group><article-title>Selenium binding protein 1 in ovarian cancer.</article-title><source>Int J Cancer</source><year>2006</year><volume>118</volume><fpage>2433</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">16380993</pub-id></mixed-citation></ref><ref id="r49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H</given-names></name></person-group><article-title>Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.</article-title><source>Proteomics</source><year>2006</year><volume>6</volume><fpage>3466</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">16645984</pub-id></mixed-citation></ref><ref id="r50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Head</surname><given-names>KA</given-names></name></person-group><article-title>Natural therapies for ocular disorders, part one: diseases of the retina.</article-title><source>Altern Med Rev</source><year>1999</year><volume>4</volume><fpage>342</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">10559549</pub-id></mixed-citation></ref><ref id="r51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohngemach</surname><given-names>S</given-names></name><name><surname>Buck</surname><given-names>C</given-names></name><name><surname>Simon</surname><given-names>P</given-names></name><name><surname>Schaeffel</surname><given-names>F</given-names></name><name><surname>Feldkaemper</surname><given-names>MP</given-names></name></person-group><article-title>Temporal changes of novel transcripts in the chicken retina following imposed defocus.</article-title><source>Mol Vis</source><year>2004</year><volume>10</volume><fpage>1019</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">15635295</pub-id></mixed-citation></ref><ref id="r52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torrealba</surname><given-names>JR</given-names></name></person-group><article-title>Selenium-binding protein-1 in smooth muscle cells is downregulated in a rhesus monkey model of chronic allograft nephropathy.</article-title><source>Am J Transplant</source><year>2005</year><volume>5</volume><fpage>58</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">15636612</pub-id></mixed-citation></ref><ref id="r53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seko</surname><given-names>Y</given-names></name><name><surname>Shimokawa</surname><given-names>H</given-names></name><name><surname>Tokoro</surname><given-names>T</given-names></name></person-group><article-title>Expression of bFGF and TGF-beta 2 in experimental myopia in chicks.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1995</year><volume>36</volume><fpage>1183</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">7730028</pub-id></mixed-citation></ref><ref id="r54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname><given-names>S</given-names></name><name><surname>Fujii</surname><given-names>S</given-names></name><name><surname>Sekiya</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name></person-group><article-title>Retinal control on the axial length mediated by transforming growth factor-beta in chick eye.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1996</year><volume>37</volume><fpage>2519</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">8933768</pub-id></mixed-citation></ref><ref id="r55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunker</surname><given-names>N</given-names></name><name><surname>Schuster</surname><given-names>N</given-names></name><name><surname>Krieglstein</surname><given-names>K</given-names></name></person-group><article-title>TGF-beta modulates programmed cell death in the retina of the developing chick embryo.</article-title><source>Development</source><year>2001</year><volume>128</volume><fpage>1933</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">11493517</pub-id></mixed-citation></ref><ref id="r56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witmer</surname><given-names>AN</given-names></name><name><surname>Vrensen</surname><given-names>GF</given-names></name><name><surname>Van Noorden</surname><given-names>CJ</given-names></name><name><surname>Schlingemann</surname><given-names>RO</given-names></name></person-group><article-title>Vascular endothelial growth factors and angiogenesis in eye disease.</article-title><source>Prog Retin Eye Res</source><year>2003</year><volume>22</volume><fpage>1</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">12597922</pub-id></mixed-citation></ref><ref id="r57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seko</surname><given-names>Y</given-names></name><name><surname>Seko</surname><given-names>Y</given-names></name><name><surname>Fujikura</surname><given-names>H</given-names></name><name><surname>Pang</surname><given-names>J</given-names></name><name><surname>Tokoro</surname><given-names>T</given-names></name><name><surname>Shimokawa</surname><given-names>H</given-names></name></person-group><article-title>Induction of vascular endothelial growth factor after application of mechanical stress to retinal pigment epithelium of the rat in vitro.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1999</year><volume>40</volume><fpage>3287</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">10586955</pub-id></mixed-citation></ref><ref id="r58"><label>58</label><mixed-citation publication-type="confproc">Nguyen KT, Wildsoet C. Long-term effect of induced myopia on vascular endothelial growth factor expression in chick retinal pigment epithelium. ARVO Annual Meeting; 2009 May 3&#x02013;7; Fort Lauderdale (FL).</mixed-citation></ref><ref id="r59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araki</surname><given-names>CM</given-names></name><name><surname>Hamassaki-Britto</surname><given-names>DE</given-names></name></person-group><article-title>Motion-sensitive neurons in the chick retina: a study using Fos immunohistochemistry.</article-title><source>Brain Res</source><year>1998</year><volume>794</volume><fpage>333</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9622668</pub-id></mixed-citation></ref><ref id="r60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Kawamura</surname><given-names>K</given-names></name><name><surname>Imaki</surname><given-names>J</given-names></name></person-group><article-title>Differential expression of c-fos mRNA in rat retinal cells: regulation by light/dark cycle.</article-title><source>Neuron</source><year>1993</year><volume>10</volume><fpage>1049</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">8318229</pub-id></mixed-citation></ref><ref id="r61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFadden</surname><given-names>SA</given-names></name><name><surname>Howlett</surname><given-names>MH</given-names></name><name><surname>Mertz</surname><given-names>JR</given-names></name></person-group><article-title>Retinoic acid signals the direction of ocular elongation in the guinea pig eye.</article-title><source>Vision Res</source><year>2004</year><volume>44</volume><fpage>643</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">14751549</pub-id></mixed-citation></ref><ref id="r62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Troilo</surname><given-names>D</given-names></name><name><surname>Nickla</surname><given-names>DL</given-names></name><name><surname>Mertz</surname><given-names>JR</given-names></name><name><surname>Summers Rada</surname><given-names>JA</given-names></name></person-group><article-title>Change in the synthesis rate of ocular retinoic acid and scleral glycosaminoglycan during experimentally altered eye growth in marmosets.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2006</year><volume>47</volume><fpage>1768</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">16638980</pub-id></mixed-citation></ref></ref-list></back></article>